Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD) antibodies represents a useful tool to estimate the individual protection against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection; (2) Methods: We evaluated anti S-RBD IgG levels by indirect c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Sasso, Bruna, Giglio, Rosaria Vincenza, Vidali, Matteo, Scazzone, Concetta, Bivona, Giulia, Gambino, Caterina Maria, Ciaccio, Anna Maria, Agnello, Luisa, Ciaccio, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306884/
https://www.ncbi.nlm.nih.gov/pubmed/34206567
http://dx.doi.org/10.3390/diagnostics11071135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306884/
https://www.ncbi.nlm.nih.gov/pubmed/34206567
http://dx.doi.org/10.3390/diagnostics11071135

Ejemplares similares